Mahoney Robert John sold $179K of ACLS

Mahoney Robert John (EVP Global Operations) sold 1,155 shares of AXCELIS TECHNOLOGIES INC (ACLS) at $155.24 ($0.18M total) on 2026-06-02.

Original reporting
SEC EDGAR · Mahoney Robert John
Published Jun 3, 2026, 9:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 3, 2026, 9:07 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ACLS
Neutral
medium confidence
Mentioned
$ACLS
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACLSNeutralLow
01

Why it matters

The disclosure provides a fresh datapoint on insider behavior (1,155-share sale at ~$155.24) but does not include any new operational or financial guidance.

02

Market read

Traders may monitor insider activity for sentiment, but this single sale is unlikely to drive a major repricing without additional catalysts.

03

What to watch

The article doesn’t show whether other insiders also sold/bought, whether the executive has compensation-driven selling schedules, or whether there’s a broader trend in insider activity.

Relevance 4/10Novelty 6/10Timing: Filed June 3; sale executed June 2 (post-transaction disclosure).

Background

This is an SEC Form 4 insider transaction disclosure for Axcelis Technologies (ACLS).

Company-level read

Ticker impact

$ACLSNeutralMedium confidence
Context

Axcelis Technologies insider (EVP Global Operations) sold 1,155 shares in an open-market transaction disclosed via SEC Form 4.

Expected impact

Low probability of a sustained move; any reaction is likely small and short-lived.

Evidence & confidence

The filing is a routine Form 4 open-market sale with no 10b5-1 plan stated and no accompanying corporate event (earnings, guidance, deal, litigation) in the article.

Market effects

Could marginally affect sentiment among semiconductor/industrial equipment peers if insider selling is interpreted as risk-off, but no sector-wide signal is provided.

None indicated.

None indicated.

Counterpoint

A non-10b5-1 sale can be routine liquidity/portfolio rebalancing; without a pattern or follow-on news, it may not signal deterioration.

Key entities

  • Axcelis Technologies Inc

    Subject of the insider transaction disclosure (ACLS).

  • Robert John Mahoney

    EVP Global Operations who sold shares via an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

Med

Axcelis Technologies, Inc. Q3 2026 Earnings Call Summary

Axcelis Technologies reported Q3 2026 earnings exceeding expectations, driven by higher revenue and lower expenses, despite FX headwinds. AI demand in data centers and memory sectors boosted performance. CS&I revenue hit a record $93M. The company expects 2027 growth and a Q1 2027 merger close with Veeco. Gross margin was 41.2%, affected by currency fluctuations. A new CFO was appointed, and operating expenses were lower than forecasted.

$ACLSHighAI 8/10

Axcelis (ACLS) Q3 2026 Earnings Call Transcript

Axcelis (ACLS) reported Q3 2026 revenue of $238M and EPS of $1.26, beating expectations. Systems revenue grew, driven by power and memory markets, while CS&I revenue hit a record. Book-to-bill ratio was 1.5. The company expects 2027 growth across memory, power, and general mature markets, supported by customer investments and new technologies.

$ACLSMed

What Axcelis Technologies (ACLS) Said on Its Q3 Earnings Call

Axcelis Technologies (ACLS) reported Q3 earnings, highlighting increased silicon carbide sales and rising power bookings. Memory sales were 20% of system sales, with DRAM revenue expected to surpass $90M in 2026. The company plans a $35M manufacturing facility in Korea. Q4 guidance includes a 42.5% gross margin and $56M adjusted EBITDA. The merger with Veeco Instruments is expected to close by Q1 2027. Jeroen Delsman will join as CFO on November 12.

$ACLSMedAI 8/10

Axcelis Announces Financial Results for Third Quarter 2026

AXCELIS TECHNOLOGIES INC (ACLS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 News Release Axcelis Announces Financial Results for Third Quarter 2026 Q3 2026 Highlights: · Revenue of $237.8 million · GAAP Gross Margin of 41.0%, and Non-GAAP Gross Margin of 41.2% · GAAP Operating Margin of 11.5% and Non-GAAP Operating Margin of 16.6% · GAAP Dil